{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:48:24Z","timestamp":1771951704520,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P01 DA009158-20"],"award-info":[{"award-number":["P01 DA009158-20"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA045882"],"award-info":[{"award-number":["R21 DA045882"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R37 DA003801"],"award-info":[{"award-number":["R37 DA003801"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejphar.2023.176168","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T04:51:33Z","timestamp":1698555093000},"page":"176168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201"],"prefix":"10.1016","volume":"960","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4888-0698","authenticated-orcid":false,"given":"Dalal","family":"AlKhelb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Zvonok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-431X","authenticated-orcid":false,"given":"Christos","family":"Iliopoulos-Tsoutsouvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markos-Orestis","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-7570","authenticated-orcid":false,"given":"Thanh C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-5292","authenticated-orcid":false,"given":"Spyros P.","family":"Nikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-5996","authenticated-orcid":false,"given":"Rajeev I.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.ejphar.2023.176168_bib1","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)00146-5","article-title":"Delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain","volume":"323","author":"Burkey","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.118.250530","article-title":"Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats","volume":"367","author":"Carlier","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.2010.00908.x","article-title":"A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents","volume":"161","author":"Cluny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0022-3565(25)10448-5","article-title":"Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol","volume":"263","author":"Compton","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2023.176168_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110301","article-title":"The synthetic CB1 cannabinoid receptor selective agonists: putative medical uses and their legalization","volume":"110","author":"Coronado-\u00c1lvarez","year":"2021","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1124\/jpet.110.173773","article-title":"Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds","volume":"335","author":"Desai","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.ejphar.2023.176168_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-003-1426-x","article-title":"Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats","volume":"167","author":"Desai","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.112.198374","article-title":"Analysis of tolerance and behavioral\/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs","volume":"344","author":"Desai","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.ejphar.2023.176168_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101764","article-title":"Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors","volume":"298","author":"Dutta","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176168_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(25)24023-X","article-title":"Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212","volume":"271","author":"Fan","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2023.176168_bib11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.ejphar.2023.176168_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/FBP.0000000000000093","article-title":"\u03949-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2\/Spice","volume":"25","author":"Gatch","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176168_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3565(24)37979-0","article-title":"Large receptor reserve for cannabinoid actions in the central nervous system","volume":"288","author":"Gifford","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2023.176168_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/jpet.111.187757","article-title":"JWH-018 and JWH-073: \u0394\u2079-tetrahydrocannabinol-like discriminative stimulus effects in monkeys","volume":"340","author":"Ginsburg","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"21","key":"10.1016\/j.ejphar.2023.176168_bib15","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"G\u00f3mez","year":"2002","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.ejphar.2023.176168_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"21","key":"10.1016\/j.ejphar.2023.176168_bib17","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1021\/jm4005626","article-title":"Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists","volume":"56","author":"Han","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176168_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of oral THC or divalproex","volume":"29","author":"Haney","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.ejphar.2023.176168_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-002-1231-y","article-title":"Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans","volume":"164","author":"Hart","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2023.176168_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/adb.12334","article-title":"Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with \u0394(9) -tetrahydrocannabinol","volume":"22","author":"Hoffman","year":"2017","journal-title":"Addiction Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/jpet.117.240572","article-title":"Apparent affinity estimates and reversal of the effects of synthetic cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by rimonabant in rhesus monkeys","volume":"362","author":"Hruba","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/jpet.112.196444","article-title":"Apparent inverse relationship between cannabinoid agonist efficacy and tolerance\/cross-tolerance produced by \u0394\u2079-tetrahydrocannabinol treatment in rhesus monkeys","volume":"342","author":"Hruba","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.ejphar.2023.176168_bib23","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"7","key":"10.1016\/j.ejphar.2023.176168_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008877-200411000-00008","article-title":"(-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats","volume":"15","author":"J\u00e4rbe","year":"2004","journal-title":"Behav. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.ejphar.2023.176168_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/FBP.0b013e328349fbd5","article-title":"Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (\u0394(9)-tetrahydrocannabinol) discrimination for rats","volume":"22","author":"J\u00e4rbe","year":"2011","journal-title":"Behav. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-011-2226-3","article-title":"Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats","volume":"216","author":"J\u00e4rbe","year":"2011","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00213-011-2491-1","article-title":"AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice","volume":"220","author":"J\u00e4rbe","year":"2012","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-013-3257-8","article-title":"Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats","volume":"231","author":"J\u00e4rbe","year":"2014","journal-title":"Psychopharmacology"},{"issue":"2\u20133 Spec Issue","key":"10.1016\/j.ejphar.2023.176168_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/FBP.0000000000000196","article-title":"\u03949-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats","volume":"27","author":"J\u00e4rbe","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176168_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pbb.2016.06.001","article-title":"A high efficacy cannabinergic ligand (AM4054) used as a discriminative stimulus: generalization to other adamantyl analogs and \u0394(9)-THC in rats","volume":"148","author":"J\u00e4rbe","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2023.176168_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2018.12.026","article-title":"Progress in brain cannabinoid CB2 receptor research: from genes to behavior","volume":"98","author":"Jordan","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.112.201962","article-title":"Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists","volume":"344","author":"Kangas","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2023.176168_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/jpet.119.261818","article-title":"Cannabinoid antagonist drug discrimination in nonhuman primates","volume":"372","author":"Kangas","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.103.060525","article-title":"Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands","volume":"309","author":"Katz","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2023.176168_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor","volume":"88","author":"Khajehali","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/ijms23020975","article-title":"New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders","volume":"23","author":"Kibret","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176168_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2125.2012.04164.x","article-title":"Novel \u03949-tetrahydrocannabinol formulation Namisol\u00ae has beneficial pharmacokinetics and promising pharmacodynamic effects","volume":"74","author":"Klumpers","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"16","key":"10.1016\/j.ejphar.2023.176168_bib38","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm058183t","article-title":"The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications","volume":"48","author":"Lambert","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.110.173260","article-title":"N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects","volume":"336","author":"Li","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"17","key":"10.1016\/j.ejphar.2023.176168_bib40","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.ejphar.2023.176168_bib41","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1021\/jm058175c","article-title":"Adamantyl cannabinoids: a novel class of cannabinergic ligands","volume":"48","author":"Lu","year":"2005","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjp.0705792","article-title":"Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist","volume":"142","author":"Luk","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.176168_bib43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1124\/jpet.106.107110","article-title":"Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol","volume":"319","author":"McMahon","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2023.176168_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2007.04.054","article-title":"Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL\/6J mice","volume":"569","author":"McMahon","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176168_bib45","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.ejphar.2023.176168_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114027","article-title":"Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists","volume":"230","author":"Papanastasiou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/jpet.110.173823","article-title":"Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal","volume":"336","author":"Paronis","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.ejphar.2023.176168_bib48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/FBP.0b013e32835a7c4d","article-title":"\u0394(9)-Tetrahydrocannabinol acts as a partial agonist\/antagonist in mice","volume":"23","author":"Paronis","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176168_bib49","doi-asserted-by":"crossref","unstructured":"Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL, Makriyannis A, Salamone JD. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacol. Biochem. Behav.. 97: 179-184. PMID 20713079 DOI: 10.1016\/J.Pbb.2010.07.021.","DOI":"10.1016\/j.pbb.2010.07.021"},{"key":"10.1016\/j.ejphar.2023.176168_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2014.06.023","article-title":"JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects","volume":"740","author":"Rodriguez","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2023.176168_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13311-015-0380-8","article-title":"Safety and toxicology of cannabinoids","volume":"12","author":"Sachs","year":"2015","journal-title":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/j.ejphar.2023.176168_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/164_2019_298","article-title":"Molecular mechanism and cannabinoid pharmacology","volume":"258","author":"Schurman","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"24","key":"10.1016\/j.ejphar.2023.176168_bib53","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.ejphar.2023.176168_bib54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00213-010-2162-7","article-title":"Tolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia","volume":"215","author":"Singh","year":"2011","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-009-1602-8","article-title":"Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats","volume":"206","author":"Sink","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2023.176168_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2015.09.006","article-title":"Repeated administration of phytocannabinoid \u0394(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner","volume":"102","author":"Tai","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.ejphar.2023.176168_bib57","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.ejphar.2023.176168_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/1389557054368772","article-title":"CB1 cannabinoid receptor ligands","volume":"5","author":"Thakur","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2023.176168_bib59","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1021\/jm4000775","article-title":"Novel adamantyl cannabinoids as CB1 receptor probes","volume":"56","author":"Thakur","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2023.176168_bib60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3565(25)23000-2","article-title":"Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency","volume":"255","author":"Thomas","year":"1990","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2023.176168_bib61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2023.176168_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.02.008","article-title":"Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice","volume":"95","author":"Vigolo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2023.176168_bib62","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)09651-X","article-title":"Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","volume":"273","author":"Walker","year":"1995","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.ejphar.2023.176168_bib63","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","article-title":"Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: opposite roles of CB1\/CB2 versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176168_bib64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3565(24)37496-8","article-title":"Structure-activity relationships of indole-and pyrrole-derived cannabinoids","volume":"285","author":"Wiley","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2023.176168_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2011.11.001","article-title":"1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice","volume":"123","author":"Wiley","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2023.176168_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pbb.2014.05.016","article-title":"Cross-substitution of \u03949-tetrahydrocannabinol and JWH-018 in drug discrimination in rats","volume":"124","author":"Wiley","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Pt A","key":"10.1016\/j.ejphar.2023.176168_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2016.07.016","article-title":"Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice","volume":"110","author":"Wiley","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923006829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923006829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:28:37Z","timestamp":1757978917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923006829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":68,"alternative-id":["S0014299923006829"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176168","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176168"}}